INO Financial Facts

Net loss/ (gain) attributable to non-controlling interest: 9.41K
Net loss: -10.83M
See Full Income Statement

Common stock warrants: 6.05M
Investment in affiliated entity: 9.29M
See Full Balance Sheet

Inovio Pharma (INO) Earnings

  |   Expand Research on INO
Next EPS Date 8/11/14 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate +35.4% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +1.3% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/12/14 Q114 -$0.05-$0.04 -$0.01$2.4M$1.41M N/A Details
3/17/14 Q413 -$0.04-$0.03 -$0.01$1.7M$1.36M N/A Details
11/12/13 Q313 $0.00-$0.02 +$0.02$9.5M$2.99M N/A Details
8/9/13 Q213 -$0.06N/A N/A $786K$436K N/A Details
3/18/13 Q412 $0.00-$0.04 +$0.04$1.1M$1.08M N/A Details
11/7/12 Q312 -$0.05-$0.05 $0.00$855K$2.07M N/A Details
8/9/12 Q212 -$0.03-$0.04 +$0.01$436K$2.07M N/A Details
5/9/12 Q112 -$0.06-$0.04 -$0.02$1.7M$2.1M N/A Details